F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
36.40
-0.04 (-0.11%)
Feb 20, 2026, 4:00 PM EST - Market closed
LFSC Holdings Information
LFSC is an equity ETF with a total of 42 individual holdings. The top holdings are Cogent Biosciences stock at 8.92%, LivaNova at 7.07%, Mirum Pharmaceuticals at 5.52%, US DOLLARS at 5.35%, and Guardant Health at 4.89%.
Total Holdings
42
Top 10 Percentage
53.08%
Asset Class
Equity
ETF Category
Health
Assets
96.81M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | COGT | Cogent Biosciences, Inc. | 8.92% |
| 2 | LIVN | LivaNova PLC | 7.07% |
| 3 | MIRM | Mirum Pharmaceuticals, Inc. | 5.52% |
| 4 | n/a | US DOLLARS | 5.35% |
| 5 | GH | Guardant Health, Inc. | 4.89% |
| 6 | TMDX | TransMedics Group, Inc. | 4.81% |
| 7 | TVTX | Travere Therapeutics, Inc. | 4.54% |
| 8 | UTHR | United Therapeutics Corporation | 4.15% |
| 9 | WVE | Wave Life Sciences Ltd. | 3.97% |
| 10 | SYRE | Spyre Therapeutics, Inc. | 3.87% |
| 11 | NKTR | Nektar Therapeutics | 3.86% |
| 12 | SVRA | Savara Inc. | 3.83% |
| 13 | KALV | KalVista Pharmaceuticals, Inc. | 3.71% |
| 14 | ICUI | ICU Medical, Inc. | 3.01% |
| 15 | BBIO | BridgeBio Pharma, Inc. | 2.72% |
| 16 | TRVI | Trevi Therapeutics, Inc. | 2.51% |
| 17 | AXSM | Axsome Therapeutics, Inc. | 2.44% |
| 18 | ACAD | ACADIA Pharmaceuticals Inc. | 2.41% |
| 19 | COLL | Collegium Pharmaceutical, Inc. | 2.23% |
| 20 | ITGR | Integer Holdings Corporation | 2.09% |
| 21 | CBLL | CeriBell, Inc. | 1.84% |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.78% |
| 23 | BLLN | BillionToOne, Inc. | 1.57% |
| 24 | GMED | Globus Medical, Inc. | 1.52% |
| 25 | CYTK | Cytokinetics, Incorporated | 1.50% |
As of Feb 18, 2026